Get started
Author

Benoît Douvry

Observed names: B Douvry, B. Douvry, Benoit DOUVRY, Benoit Douvry, benoît Douvry, Douvry, B.
Observed institutions: Inserm, Université Paris-Est Créteil, Université de Montpellier, Centre Hospitalier Universitaire Vaudois, Institut des Sciences Moléculaires, Physiologie et Médecine Expérimentale du Coeur et des Muscles, Sorbonne Paris Cité, Centre Hospitalier Universitaire de Montpellier, Assistance Publique – Hôpitaux de Paris, University Hospital Zurich, Hôpital Européen Georges-Pompidou, Hôpitaux Universitaires Henri-Mondor, Hôpital Arnaud de Villeneuve, Ecologie microbienne, Hôpital Foch, Hôpital Intercommunal de Créteil, Institut Mondor de Recherche Biomédicale, Université Paris Descartes
ORCID: 0009-0006-6547-1366
Observed ORCID: 0009-0006-6547-1366
OpenAlex ID: A5032183699
Nocardia Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study
2016 · Julien Coussement, for the European Study Group for Nocardia in Solid Organ Transplantation, et al. · Clinical Infectious Diseases · 267
Antibody-Mediated Rejection in Lung Transplantation: Clinical Outcomes and Donor-Specific Antibody Characteristics
2016 · A. Roux, I. Bendib Le Lan, et al. · American Journal of Transplantation · 146
Outcome and Treatment of Nocardiosis After Solid Organ Transplantation: New Insights From a European Study
2017 · David Lebeaux, Romain Freund, et al. · Clinical Infectious Diseases · 120
PDF
The French Compassionate Program of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del CFTR variant
2023 · Pierre-Régis Burgel, Isabelle Sermet-Gaudelus, et al. · European Respiratory Journal · 102
Lung transplantation for scleroderma lung disease: An international, multicenter, observational cohort study
2018 · Pauline Pradère, Igor Tudorache, et al. · The Journal of Heart and Lung Transplantation · 99
Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescription
2023 · Elise Dreano, Pierre Régis Burgel, et al. · European Respiratory Journal · 96
Airway microbiota signals anabolic and catabolic remodeling in the transplanted lung
2017 · Stéphane Mouraux, Eric Bernasconi, et al. · Journal of Allergy and Clinical Immunology · 70
PDF
Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis
2022 · Clémence Martin, Martine Reynaud-Gaubert, et al. · Journal of Cystic Fibrosis · 67
The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study
2024 · Pierre-Régis Burgel, Isabelle Sermet-Gaudelus, et al. · The Lancet Respiratory Medicine · 63
PDF
Multisystemic Effects of Elexacaftor–Tezacaftor–Ivacaftor in Adults with Cystic Fibrosis and Advanced Lung Disease
2024 · Pierre-Régis Burgel, Jean-Louis Paillasseur, et al. · Annals of the American Thoracic Society · 48
Characteristics of Donor-Specific Antibodies Associated With Antibody-Mediated Rejection in Lung Transplantation
2017 · Antoine Roux, Ines Bendib Le Lan, et al. · Frontiers in Medicine · 36
PDF
High Emergency Lung Transplantation: dramatic decrease of waiting list death rate without relevant higher post-transplant mortality
2015 · Antoine Roux, Laurence Beaumont-Azuar, et al. · Transplant International · 33
Outcome of patients with interstitial lung disease admitted to the intensive care unit.
2013 · A Vial-Dupuy, O Sanchez, et al. · PubMed · 22
Posaconazole Tablets in Real-Life Lung Transplantation: Impact on Exposure, Drug-Drug Interactions, and Drug Management in Lung Transplant Patients, Including Those with Cystic Fibrosis
2018 · Manon Launay, Antoine Roux, et al. · Antimicrobial Agents and Chemotherapy · 21
Sweat chloride and lung function responses to elexacaftor–tezacaftor–ivacaftor in people with cystic fibrosis with two versus one responsive CFTR variants: an analysis of two real-world observational studies
2025 · Pierre-Régis Burgel, Jennifer Da Silva, et al. · The Lancet Respiratory Medicine · 18
Cardiopulmonary Exercise Testing Provides Prognostic Information in Advanced Cystic Fibrosis Lung Disease
2023 · Thomas Radtke, Don S. Urquhart, et al. · Annals of the American Thoracic Society · 13
Tobacco-associated pulmonary vascular dysfunction in smokers: role of the ET-1 pathway
2011 · Priscilla Henno, Jean-François Boitiaux, et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 13
Beyond Trikafta: new models to assess tissue dependent rescue of N1303K-CFTR
2025 · Iwona Pranke, Valeria Capurro, et al. · Frontiers in Pharmacology · 10
PDF
Anti–IL-4R versus anti–IL-5/5R after anti–IL-5/5R failure in asthma: An emulated target trial
2024 · Solène Valery, Noémie Simon-Tillaux, et al. · Journal of Allergy and Clinical Immunology · 9
PDF
Outcome Of Patients With Interstitial Lung Disease Admitted To An Intensive Care Unit
2012 · Amandine Vial Dupuy, Olivier Sanchez, et al. · American Journal of Respiratory and Critical Care Medicine · 9
Évolution et progrès en transplantation pulmonaire : étude de la cohorte de 600 premiers patients transplantés pulmonaires à l’hôpital Foch
2019 · A. Roux, E. Sage, et al. · Revue des Maladies Respiratoires · 8
Impact of the COVID-19 pandemic and associated lockdown measures on the management, health, and behavior of the cystic fibrosis population in France during 2020 (MUCONFIN)
2022 · Nadia Oubaya, Thibaut Pombet, et al. · Frontiers in Public Health · 7
French consensus statement on transition of adolescent and young adults with rare pulmonary disease from paediatric to adult care: a Delphi method study
2025 · Elora Peulier-Maitre, Myrofora Goutaki, et al. · ERJ Open Research · 5
Beyond Kaftrio : mechanistic insights to maximize N1303K-CFTR rescue
2024 · Iwona Pranke, Valeria Capurro, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2
PDF
Impact of a rare respiratory diseases reference centre set-up on primary ciliary dyskinesia care pathway
2021 · Salome Epaud, Ralph Epaud, et al. · European Respiratory Journal · 2
PDF
Works count: 73
Citation count: 1,451
H-index: 18
I10-index: 21
Year
Topic
Type